The FDA still needs to officially authorize molnupiravir for people at high risk of severe COVID-19.

Topics:  fda   covid-19   authorize   
BING NEWS:
  • Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval
    The Tuesday approval of the Merck drug covers the treatment of adults whose pulmonary arterial hypertension (PAH) is at intermediate or high risk of progression. The drug, known in development as ...
    03/28/2024 - 7:39 pm | View Link
  • FDA approves Merck treatment for lung disease, potential path to upside
    The Food and Drug Administration has approved Winrevair, Merck's (MRK) latest drug to treat ... joins The Morning Brief to discuss how the treatment could offer a potential path to the upside ...
    03/26/2024 - 1:00 pm | View Link
  • Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair
    After three years, the crown jewel of Merck’s $11.5 billion acquisition of Acceleron ... is set to launch the first disease-modifying treatment for the condition. Initially developed by ...
    03/26/2024 - 6:11 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News